Effects of candesartan cilexetil in patients with systemic hypertension-Reference-Cited by-同舟云学术

Effects of candesartan cilexetil in patients with systemic hypertension

Published:1998-10 Issue:8 Volume:82 Page:961-965
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Reif Max,White William B.,Fagan Timothy C.,Oparil Suzanne,Flanagan Terry L.,Edwards Dianne T.,Cushing Daniel J.,Michelson Eric L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference7 articles.

1. Angiotensin receptors and their antagonists;Goodfriend;N Engl J Med,1996

2. Gavras I, Gavras H. Angiotensin II—possible adverse effects on arteries, heart, brain, and kidney: experimental, clinical, and epidemiological evidence. In: Robertson JIS, Nicholls MG, eds. The Renin-Angiotensin System. Vol. 1. Biochemistry/Physiology. London: Gower Medical Publishing, 1993:40.1–40.11.

3. The chymase-angiotensin system in humans;Liao;Can J Cardiol,1995

4. Candesartan cilexetil;Nishikawa;J Human Hypertens,1997

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction;JACC: Heart Failure;2020-03

2. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions;Int. Journal of Clinical Pharmacology and Therapeutics;2019-08-01

3. Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study;Journal of Clinical Pharmacy and Therapeutics;2016-09-27

4. Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses;The Journal of Clinical Pharmacology;2016-03-07

5. Once again about the clinical efficacy and safety of sartans;Systemic Hypertension;2014-12-15